Another study showed that FZD2 was expressed in tumorous HCC tissue but not in the surrounding nontumorous tissue and that the proliferative capacity of hepatocellular carcinoma cells was decreased after transfection with FZD2-targeting shRNA. This evidence concerns the gene FZD2 and hepatocellular carcinoma.